Plain-English translation of NCT07482917 on ClinicalTrials.gov ↗ · Source last updated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a better-organized diagnostic process can help doctors diagnose interstitial lung disease—a serious condition where lung tissue becomes scarred and stiff—more quickly. Right now, patients with suspected lung scarring often have to make many separate hospital visits for different tests (like imaging, breathing tests, and blood work) that take place on different days. This study compares the standard scattered approach to a streamlined approach where all the necessary tests are coordinated and clustered into as few visits as possible.
Patients with suspected interstitial lung disease often wait a long time for a final diagnosis because diagnostic tests are spread out over many visits, which delays treatment and causes stress, extra costs, and more time away from work. This trial exists to see whether organizing all tests into a coordinated schedule can help people get answers faster and reduce the burden on patients and their families.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to either the standard diagnostic pathway (where tests are scheduled normally) or the optimized pathway (where tests are coordinated into fewer visits). You will complete the same diagnostic tests either way—such as chest imaging, breathing tests, and blood work—but the timing and coordination may differ. Throughout the process, you will also answer questionnaires about your quality of life, mood, and any anxiety or depression you may be experiencing to help researchers understand the impact of the diagnostic process.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Spain